Recall Enforment Report D-0676-2017
Recall Details
Drug Recall Enforcement Report Class II voluntary initiated by Taro Pharmaceuticals U.S.A., Inc., originally initiated on 03-28-2017 for the product Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (NDC 51672-1263-1), b) 30 grams (NDC 51672-1263-2) and c) 60 grams (NDC 51672-1263-3) tubes, Rx only, TARO label; Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 -- Dist. by: Taro Pharmaceuticals U.S.A. Inc., Hawthorne, NY 10532 The product was recalled due to failed content uniformity specifications; out-of-specification (oos) results 18-month stability. The product was distributed nationwide and the recall is currently terminated.
| Field Name | Field Value | 
|---|---|
| Event ID | 76954  What is the Event ID? A numerical designation assigned by FDA to a specific recall event (used for tracking purposes). | 
| Recall Number | D-0676-2017  What is the Recall Number? An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes). | 
| Recall Classification | Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote  What is the Recall Classification? Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified". | 
| Distribution Pattern | Nationwide and Puerto Rico  What is the Distribution Pattern? General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included. | 
| Product Description | Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (NDC 51672-1263-1), b) 30 grams (NDC 51672-1263-2) and c) 60 grams (NDC 51672-1263-3) tubes, Rx only, TARO label; Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 -- Dist. by: Taro Pharmaceuticals U.S.A. Inc., Hawthorne, NY 10532 | 
| Reason For Recall | Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability  What is the Reason for Recall? Information describing how the product is defective. | 
| Product Quantity | 278,304 tubes  Product Quantity The amount of product subject to recall. | 
| Voluntary Mandated | Voluntary: Firm initiated  Voluntary / Mandated Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order. | 
| Report Date | 04-26-2017 | 
| Recall Initiation Date | 03-28-2017  What is the Recall Initiation Date? The date that the firm first began notifying the public or their consignees of the recall. | 
| Termination Date | 06-17-2019  What is the Date Terminated? The date that FDA terminated the recall. | 
| Initial Firm Notification | Letter  Initial Firm Notification of Consignee or Public The method(s) by which the firm initially notified the public or their consignees of a recall. | 
| Product Type | Drugs | 
| Recalling Firm | Taro Pharmaceuticals U.S.A., Inc. | 
| Code Info | a) 15 g: Lot B505118501, exp. date January 2018;   b) 30 g: Lot B504918500, exp. date January 2018;  c) 60 g: Lots: I416616979, exp. date August 2017,                      I416716979, exp. date August 2017 and                     D504519119, exp. date March 2018  Code Information A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling. | 
| Recalled NDC Packages | 51672-1272-1; 51672-1272-2; 51672-1272-3; 51672-1263-1; 51672-1263-2; 51672-1263-3 | 
| Status | Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. | 
Recalled Products
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type | 
|---|---|---|---|---|---|---|
| 51672-1263 | Nystatin And Triamcinolone Acetonide | Nystatin And Triamcinolone Acetonide | Cream | Topical | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug | 
| 51672-1272 | Nystatin And Triamcinolone Acetonide | Nystatin And Triamcinolone Acetonide | Ointment | Topical | Sun Pharmaceutical Industries, Inc. | Human Prescription Drug |